Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
US9375440B2 · kind B2 · utility
0Cited by
57References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 3, 2006 |
| Grant date | Jun 28, 2016 |
| Priority date | — |
| Expiry date | Jan 26, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compositions methods and kits for regulation of gene therapies, including, without limitation, reversible gene therapies and allele-specific therapies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.